Glaukos GKOS
NYSE GKOS
$181.46 -3.57 (-1.93%)
As of: Sep 9, 2026 · 12:52 PM EDT

Glaukos (GKOS) Operating Income (2014 - 2026)

Glaukos' (GKOS) quarterly Operating Income came in at -$17.3 million in Q2 2026, up 23.9% year-over-year from -$13.9 million in Q2 2025, and up 13.04% quarter-over-quarter from -$19.9 million in Q1 2026.

Analysis

Glaukos (GKOS) Operating Income (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has reported Operating Income for 13 consecutive years, with -$17.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Income rose 23.9% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$193.4 million, a 99.97% decrease from a year earlier, with the FY2025 full-year figure at -$199.6 million, down 63.12% from the prior year.
  • Operating Income was -$17.3 million for Q2 2026 at Glaukos, up from -$19.9 million in the prior quarter.
  • Over five years, Operating Income peaked at $9.8 million in Q1 2022 and troughed at -$139.9 million in Q4 2025.
  • A 5-year average of -$31.7 million and a median of -$28.3 million in 2023 frame the typical range for Operating Income.
  • Across the five-year window, Operating Income soared 182.95% in 2022 and slumped 436.94% in 2023, its largest moves.
  • Over 5 years, Operating Income stood at -$33.7 million in 2022, then declined by 14.49% to -$38.6 million in 2023, then climbed by 25.78% to -$28.7 million in 2024, then slumped by 387.92% to -$139.9 million in 2025, then jumped by 87.65% to -$17.3 million in 2026.
  • The last three Operating Income figures came in at -$17.3 million (Q2 2026), -$19.9 million (Q1 2026), and -$139.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn 971.90 Mn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn 1.76 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn 513.20 Mn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn 318.30 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 285.80 Mn
10 Glaukos 10.70 Bn 10.59 Bn 151.59 Mn -17.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.27 Mn
Mar 31, 2026 -19.86 Mn
Dec 31, 2025 -139.87 Mn
Sep 30, 2025 -16.37 Mn
Jun 30, 2025 -22.69 Mn
Mar 31, 2025 -20.68 Mn
Dec 31, 2024 -28.67 Mn
Sep 30, 2024 -24.66 Mn
Jun 30, 2024 -29.97 Mn
Mar 31, 2024 -39.07 Mn
Dec 31, 2023 -38.62 Mn
Sep 30, 2023 -28.01 Mn
Jun 30, 2023 -29.08 Mn
Mar 31, 2023 -32.99 Mn
Dec 31, 2022 -33.73 Mn
Sep 30, 2022 -21.61 Mn
Jun 30, 2022 -36.76 Mn
Mar 31, 2022 9.79 Mn
Dec 31, 2021 -17.87 Mn
Sep 30, 2021 11.02 Mn